摘要
目的观察外用结肠散联合美沙拉嗪肠溶片治疗溃疡性结肠炎的临床疗效。方法选取2017年1月至2018年1月本院诊治的溃疡性结肠炎患者63例为研究对象,随机分为两组,对照组31例,治疗组32例。对照组采用美沙拉嗪肠溶片治疗,治疗组在对照组的基础上采用外用结肠散治疗,比较两组的治疗效果。结果治疗组的总有效率为93.8%,显著高于对照组的77.4%,差异有统计学意义(P <0.05)。治疗组复发率为12.5%,显著低于对照组的22.6%,差异有统计学意义(P <0.05)。结论外用结肠散联合美沙拉嗪肠溶片治疗溃疡性结肠炎效果显著,可有效改善患者的临床治疗效果,降低患者的复发率。
Objective To explore the effect of Waiyongjiechang powder combined with mesalazin enteric-coated tablets in the treatment of ulcerative colitis.Methods 63 patients with ulcerative colitis from January 2017 to January 2018 in our hospital were selected and randomly divided into treatment groupwith 32 patients and control group with 31 patients. The control group was treated with mesalazin enteric-coated tablets, the treatment group was treatedwith Waiyongjiechang powder on the basis of the control group. The therapeutic effect of two groups was compared. Results The total effective rate ofthe treatment group was 93.8%,which was higher than 77.4% of the control group, with significant difference （P 〈0.05）. The relapse rate of the treatmentgroup was 12.5%, which was lower than 22.6% of the control group, with significant difference （P 〈0.05）. Conclusion The effect of Waiyongjiechangpowder combined with mesalazin enteric-coated tablets in the treatment of ulcerative colitis is significant, can improve clinical symptoms, reduce therelapse rate.
作者
王明华
WANG Ming-hua(Shenyang Anorectal Hospital,Shenyang 110000,China)
出处
《中国医药指南》
2018年第34期21-22,共2页
Guide of China Medicine
关键词
外用结肠散
美沙拉嗪肠溶片
溃疡性结肠炎
临床疗效
Waiyongjiechang powder
Mesalazin enteric-coated tablets
Ulcerative colitis
Clinical efficacy
